highly significantP <0.001
Exogenous melatonin treatment (MS) further dramatically increased the MT level to 505.0 μg·g -1 , which was 78.9% and 63.1% higher than that of the CK and S groups, respectively, and the differences between the groups all reached highly significant levels ( P <0.001).